LAACLUB 2026

Programme Overview

The LAAClub is a digital series dedicated to optimizing the LEAN LAAC patient journey. It provides a platform to explore clinical evidence, share real-world experiences, and enhance education on AF management and stroke prevention in patients with atrial fibrillation.

Learning Objectives

  • Explore the evolution of Watchman devices and assess advancements in seal, simplicity, and safety.
  • Optimize and streamline workflow using the full WATCHMAN portfolio. All-in-One Solution with VersaCross Connect, TruSteer and WATCHMAN FLX Pro.
  • Share and implement best practices for procedural workflow optimization.
  • Engage all in case-based discussions.

 the LAAClub in April 2026

"Champion-AF: A New Chapter in Stroke Prevention for AF Patients"  

LAAC vs. lifelong anticoagulation - time to reconsider?

Learning Objectives:

  • Summarize the design, endpoints and key outcomes of the Champion-AF trial,
  • Place the Champion-AF results in context with the major NOAC landmark trials,
  • Evaluate which Afib-patients may benefit from LAAC as part of long-term stroke prevention strategies,
  • Discuss how procedural workflow and integrated LAAC technologies can support clinical outcomes and patient management.

The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.

This material not intended for use in France.